TCG Crossover Management, LLC - Q3 2023 holdings

$679 Million is the total value of TCG Crossover Management, LLC's 26 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .

 Value Shares↓ Weighting
SVRA NewSAVARA INC.$37,800,00010,000,000
+100.0%
5.57%
TSHA NewTAYSHA GENE THERAPIES, INC.$35,111,11111,111,111
+100.0%
5.17%
INBX NewINHIBRX,INC$32,119,6011,750,387
+100.0%
4.73%
CMPS NewCOMPASS PATHWAYS PLCadrs$28,549,2003,858,000
+100.0%
4.20%
TARS NewTARSUS PHARMACEUTICALS, INC.$20,308,5691,142,857
+100.0%
2.99%
NewRAYZEBIO, INC.$19,311,958869,908
+100.0%
2.84%
CNTA NewCENTESSA PHARMACEUTICALS PLC$13,204,0792,040,816
+100.0%
1.94%
GRCL NewGRACELL BIOTECHNOLOGIES INC.adrs$8,752,0003,038,889
+100.0%
1.29%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
COGENT BIOSCIENCES INC8Q3 202315.6%
AEROVATE THERAPEUTICS INC8Q3 20236.5%
TYRA BIOSCIENCES INC8Q3 20236.2%
ENTRADA THERAPEUTICS INC8Q3 20235.3%
MERUS N.V.8Q3 20233.4%
IVERIC BIO INC7Q2 202324.4%
Geron Corporation7Q3 202312.4%
ACLARIS THERAPEUTICS INC7Q2 20237.9%
KURA ONCOLOGY INC7Q3 20239.1%
ALPINE IMMUNE SCIENCES INC7Q2 20237.6%

View TCG Crossover Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
TCG Crossover Management, LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Silence Therapeutics plcAugust 19, 20226,314,6255.9%
CymaBay Therapeutics, Inc.November 29, 20215,905,4007.0%
Cogent Biosciences, Inc.November 17, 20212,716,0426.8%
Tyra Biosciences, Inc.September 29, 2021937,5002.2%
Viridian Therapeutics, Inc.\DESeptember 29, 20211,314,0008.2%

View TCG Crossover Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
SC 13G2022-08-19
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-18

View TCG Crossover Management, LLC's complete filings history.

Compare quarters

Export TCG Crossover Management, LLC's holdings